191 related articles for article (PubMed ID: 35912197)
61. Predicting regional recurrence and prognosis in stereotactic body radiotherapy-treated clinical stage I non-small cell lung cancer using a radiomics model constructed with surgical data.
Ni J; Chen H; Yu L; Guo T; Zhou Y; Jiang S; Ye R; Yang X; Chu L; Chu X; Li H; Liu W; Gu Y; Yuan Z; Gong J; Zhu Z
Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38936632
[TBL] [Abstract][Full Text] [Related]
62. [Exploration of lymph node metastasis and appropriate lymph node dissection modes in patients with clinical stage I non-small cell lung cancer].
Zhang Z; Mao Y; He J; Gao S; Cheng G; Liu X; Fang D; Li J; Wang Y; Wang D; Mu J; Xue Q; Gao Y; Zhao J; Zhang L; Huang J; Wang B; Ding N
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):536-40. PubMed ID: 25327661
[TBL] [Abstract][Full Text] [Related]
63. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter.
Fang C; Xiang Y; Han W
BMC Surg; 2022 Apr; 22(1):153. PubMed ID: 35488235
[TBL] [Abstract][Full Text] [Related]
64. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
[TBL] [Abstract][Full Text] [Related]
65. [Relationship between EGFR, ALK Gene Mutation and Imaging
and Pathological Features in Invasive Lung Adenocarcinoma].
Yang H; Liu Z; Wang H; Chen L; Wang J; Wen W; Xu X; Zhu Q
Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):147-155. PubMed ID: 35340157
[TBL] [Abstract][Full Text] [Related]
66. [Correlation between the new lung adenocarcinoma classification and epidermal growth factor receptor mutation].
Zhang XD; Liu DR
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):640-644. PubMed ID: 30122764
[TBL] [Abstract][Full Text] [Related]
67. Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer.
Bao F; Yuan P; Yuan X; Lv X; Wang Z; Hu J
J Thorac Dis; 2014 Dec; 6(12):1697-703. PubMed ID: 25589962
[TBL] [Abstract][Full Text] [Related]
68. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
69. Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller.
Hung JJ; Yeh YC; Wu YC; Chou TY; Hsu WH
J Thorac Oncol; 2017 Dec; 12(12):1824-1833. PubMed ID: 28739441
[TBL] [Abstract][Full Text] [Related]
70. Nomogram based on prognostic nutrition index and Chest CT imaging signs predicts lymph node metastasis in NSCLC patients.
Chen M; Yang Y; He C; Chen L; Cheng J
J Xray Sci Technol; 2022; 30(3):599-612. PubMed ID: 35311733
[TBL] [Abstract][Full Text] [Related]
71. Prognostic significance of micropapillary and solid patterns in stage IA lung adenocarcinoma.
Peng B; Li G; Guo Y
Am J Transl Res; 2021; 13(9):10562-10569. PubMed ID: 34650727
[TBL] [Abstract][Full Text] [Related]
72. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
[TBL] [Abstract][Full Text] [Related]
73. Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma.
Suzuki M; Matsumoto Y; Imabayashi T; Teishikata T; Tsuchida T; Asamura H; Yatabe Y
Lung Cancer; 2021 Dec; 162():147-153. PubMed ID: 34814012
[TBL] [Abstract][Full Text] [Related]
74. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
[TBL] [Abstract][Full Text] [Related]
75. Genetic alterations in lung adenocarcinoma with a micropapillary component.
Furukawa M; Toyooka S; Ichimura K; Yamamoto H; Soh J; Hashida S; Ouchida M; Shien K; Asano H; Tsukuda K; Miyoshi S
Mol Clin Oncol; 2016 Feb; 4(2):195-200. PubMed ID: 26893860
[TBL] [Abstract][Full Text] [Related]
76. Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma.
Hayashi T; Saito T; Fujimura T; Hara K; Takamochi K; Mitani K; Mineki R; Kazuno S; Oh S; Ueno T; Suzuki K; Yao T
PLoS One; 2013; 8(12):e81883. PubMed ID: 24339976
[TBL] [Abstract][Full Text] [Related]
77. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter.
Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J
Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662
[TBL] [Abstract][Full Text] [Related]
78. Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases.
Yu Y; Jian H; Shen L; Zhu L; Lu S
Eur J Surg Oncol; 2016 Nov; 42(11):1714-1719. PubMed ID: 27017272
[TBL] [Abstract][Full Text] [Related]
79. Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer.
Sumii A; Hida K; Sakai Y; Hoshino N; Nishizaki D; Akagi T; Fukuda M; Yamaguchi T; Takemasa I; Tokunaga T; Watanabe J; Watanabe M
Int J Clin Oncol; 2022 Jul; 27(7):1173-1179. PubMed ID: 35415787
[TBL] [Abstract][Full Text] [Related]
80. A nomogram prediction model for lymph node metastasis in endometrial cancer patients.
Wang Z; Zhang S; Ma Y; Li W; Tian J; Liu T
BMC Cancer; 2021 Jun; 21(1):748. PubMed ID: 34187416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
